A rapid and easy-to-use spinal muscular atrophy screening tool based on primers with high specificity and amplification efficiency for SMN1 combined with single-stranded tag hybridization assay
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0308179 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Masaki Hirano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan. Hauptthemen laut MEDLINE: Survival of Motor Neuron 1 Protein, Muscular Atrophy, Spinal, DNA Primers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Craif Inc..
Abstract (Originalsprache)
Spinal muscular atrophy (SMA) is an intractable neuromuscular disorder primarily caused by homozygous deletions in exon 7 of the SMN1 gene. Early diagnosis and prompt treatment of patients with SMA have a significant impact on prognosis, and several therapies have recently been developed. Current SMA screening tests require a significant turnaround time to identify patients with suspected SMA, due both to the interval between the birth of a newborn and the collection of blood for newborn mass screening and the difficulty in distinguishing between SMN1 and SMN2 , a paralog gene that requires testing in specialized laboratories. The aim of this study was therefore to develop a novel SMA screening assay that can be rapidly performed in ordinary hospitals and clinics to overcome these issues. We designed over 100 combinations of forward and reverse primers with 3′ ends targeting SMN1 -specific sites around exon 7, and evaluated their specificity and amplification efficiency by quantitative PCR to identify the best primer pair. Furthermore, we performed a single-stranded tag hybridization assay after PCR. To evaluate the accuracy and practicality of the newly developed assay, we analyzed saliva specimens from five patients with SMA and two SMA carriers collected in an outpatient clinic and DNA specimens from three patients with SMA and four SMA carriers from a biobank, together with those from healthy individuals. DNA and raw saliva specimens from all patients with SMA demonstrated a biallelic loss of SMN1 , whereas those from carriers and healthy individuals did not. The results of 50 independent experiments were consistent for all samples. The assay could be completed within one hour. This simple and convenient new screening tool has the potential to allow patients with SMA to receive disease-modifying therapies within a shorter timeframe.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
- Craif Inc., Tokyo, Japan.
- Department of Clinical Research Education, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
- Institute of Innovation for Future Society of Nagoya University, Nagoya, Aichi, Japan.
- Kawamura Medical Associates, Nagoya, Aichi, Japan.
ORCID-Profile: Masaki Hirano
Förderung
- Craif Inc.
Zitieren
APA
Hirano, M., Sahashi, K., Ichikawa, Y., Katsuno, M., & Natsume, A. (2024). A rapid and easy-to-use spinal muscular atrophy screening tool based on primers with high specificity and amplification efficiency for SMN1 combined with single-stranded tag hybridization assay. PLOS ONE. https://doi.org/10.1371/journal.pone.0308179
Vancouver
Hirano M, Sahashi K, Ichikawa Y, Katsuno M, Natsume A. A rapid and easy-to-use spinal muscular atrophy screening tool based on primers with high specificity and amplification efficiency for SMN1 combined with single-stranded tag hybridization assay. PLOS ONE. 2024. doi:10.1371/journal.pone.0308179
BibTeX
@article{Hirano2024,
author = {Hirano, Masaki and Sahashi, Kentaro and Ichikawa, Yuki and Katsuno, Masahisa and Natsume, Atsushi},
title = {A rapid and easy-to-use spinal muscular atrophy screening tool based on primers with high specificity and amplification efficiency for SMN1 combined with single-stranded tag hybridization assay},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0308179}
}
EUVIMED